SSGI (OTCMKTS:VICP) Trading Up 240% – Time to Buy?

SSGI Inc. (OTCMKTS:VICP) shares rose 240% during trading on Thursday . The company traded as high as $0.51 and last traded at $0.51. Approximately 100 shares were traded during mid-day trading, an increase of 100% from the average daily volume of 50 shares. The stock had previously closed at $0.15.

SSGI Stock Up 94.1%

The firm has a market cap of $32.05 million, a P/E ratio of -24.75 and a beta of 4.95. The company has a 50 day moving average of $1.44 and a two-hundred day moving average of $1.54.

SSGI Company Profile

Vicapsys Life Sciences, Inc focuses on the development and commercialization of VICAPSYN, a proprietary product. The company’s product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc and changed its name to Vicapsys Life Sciences, Inc in September 2017.